{"id":313261,"date":"2026-10-16T11:39:05","date_gmt":"2026-10-16T06:09:05","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=313261"},"modified":"2026-10-16T11:39:05","modified_gmt":"2026-10-16T06:09:05","slug":"qline-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/qline-best-stock-in-its-sector\/","title":{"rendered":"Is Q-Line Biotech the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"

Q-Line Biotech CMP Rs 598 (16 Oct 2026). Market cap Rs 1,396 Cr. ROE 22.63%. P\/E 25.04x versus Industry P\/E 54.37x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Q-Line Biotech is one of the names investors compare when screening the Healthcare sector. Whether it is the best stock in its sector depends on whether an investor prioritises return ratios, valuation or balance sheet strength. This article sets it against two named peers and the sector benchmark so you can judge for yourself.<\/p>\n<\/p><\/div>\n

Is Q-Line Biotech<\/a> the best stock in its sector? The stock trades on the NSE at Rs 598 as of 16 October 2026, within its 52-week range of Rs 431.00 to Rs 735.00. The sections below cover the business, the key ratios, a peer comparison and a closer look at valuation.<\/p>\n

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n